Erik Anders Kronström
Directeur des opérations chez INFANT BACTERIAL THERAPEUTICS AB
Fortune : 89 953 $ au 30/04/2024
Postes actifs de Erik Anders Kronström
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Directeur des opérations | 01/01/2018 | - |
| Directeur Technique/Scientifique/R&D | 20/10/2014 | 01/01/2018 |
Historique de carrière de Erik Anders Kronström
Anciens postes connus de Erik Anders Kronström
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Directeur Général | - | - |
Formation de Erik Anders Kronström
| Royal Institute of Technology | Graduate Degree |
| Warwick Business School | Masters Business Admin |
Statistiques
Internationale
| Suède | 3 |
| Norvège | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
- Bourse
- Insiders
- Erik Anders Kronström
- Expérience
